Lilly said it’s moving ‘with urgency toward global regulatory submissions to potentially meet the needs of patients who are ...

A competitor reported a successful late-stage clinical trial of a drug that could be very competitive with Wegovy.

Novo Nordisk NVO suffered a major setback in July after slashing its 2025 sales and profit outlook, triggering a decline in ...

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

A DAILY weight loss pill, tipped to be cheaper than popular jabs, has helped patients shed nearly two stone in trials. People ...

In new Phase III trial data released Tuesday, people taking orforglipron lost substantially more weight than people taking a ...

With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder how your morning cup might ...

When Serena Williams told NBC’s “TODAY” show, “I just couldn’t get my weight to where I needed to be at a healthy place and ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

The 36-mg dose brought the greatest weight loss, 10.5%, while the 12-mg dose group shed 7.8% of their body weight on average.

An embattled Iowa telepharmacy owner, fined $25,000 for selling fake Ozempic, says he didn't know the weight-loss drug was counterfeit ...

Eli Lilly said its once-daily weight loss pill was effective for people with obesity and type 2 diabetes in a key trial, ...